Company / Capital Returned to Shareholders
Centessa Pharmaceuticals plc Capital Returned to Shareholders History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$12.0K
FY2021
5-year range
$12.0K / $12.0K
FY2019-FY2021
Trend
-
vs FY2020
Sector context
#47 of 52
Health Care
What the data says
Among 52 Health Care companies, Centessa Pharmaceuticals plc is in the bottom 10% for capital returned to shareholders. Improved from $0 to $12,000 over the past 2 years.
Based on SEC 10-K filings.
$12,000 in FY2021.
Improved from $0 to $12,000 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 52This company $12.0K Sector average $1.3B
▼
-100.0% below sector average
Key checks
Key Insights
- Ranks #47 out of 52 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $12.0K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
As of FY2021 · SEC 10-K · Updated Jul 2, 2026